Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
07/2000
07/26/2000EP1021442A1 8-azabicyclo 3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors
07/26/2000EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive
07/26/2000EP1021185A1 Didhydropyrimidines and uses thereof
07/26/2000EP1021182A1 Indeno[1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activity
07/26/2000EP1021173A1 Use of csaid?tm compounds for the management of uterine contractions
07/26/2000CN1261350A Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
07/26/2000CN1261349A Chalcones having antiproliferactive activity
07/26/2000CN1261347A Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives
07/26/2000CN1261273A Delayed-release dosage forms of sertraline
07/26/2000CN1260997A Medicine for treating male sterility and weak sperm disease
07/26/2000CN1054856C New 19-nor steroids having phenoxyalkylsulphonemide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical
07/26/2000CN1054850C Piperazine compounds used in therapy
07/26/2000CN1054771C Nourishing yin and strengthening kidney pill
07/26/2000CA2296965A1 Use of bacterium for manufacture of a vaccine
07/25/2000US6093838 Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
07/25/2000US6093730 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
07/25/2000US6093710 Benzothiophene derivatives, their preparation and use as urokinase inhibitors
07/25/2000US6093709 Administering a therapeutic beta isozyme of protein kinase c inhibitor for inducing smooth muscle relaxation and vasodilation
07/25/2000US6093707 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
07/25/2000US6093394 Vaginal lactobacillus medicant
07/25/2000US6093390 Methods for promoting functional regeneration of mammalian muscle by administering leukaemia inhibitor factor
07/25/2000CA2205285C Benzoic acid derivative and pharmaceutical composition
07/25/2000CA2197086C (azetidin-1-ylalkyl)lactams as tachykinin antagonists
07/20/2000WO2000042172A2 Human homologues of proteins regulated by circadian rhythms
07/20/2000WO2000042038A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042037A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042036A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
07/20/2000WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
07/20/2000WO2000042023A1 Substituted imidazoles, their preparation and use
07/20/2000WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity
07/20/2000WO2000042018A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
07/20/2000WO2000041545A2 Regulators of the pct or smoothened pathway, compositions and uses related thereto
07/20/2000WO2000041505A2 Anthranilic acid derivatives
07/20/2000WO2000019990A3 Rar antagonists as male anti-fertility agents
07/20/2000DE19855013A1 Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element Androgen and progesterone receptor binding hormone response element
07/20/2000CA2660344A1 Improved saponin adjuvant compositions and methods relating thereto
07/20/2000CA2370042A1 Regulators of the pct or smoothened pathway, compositions and uses related thereto
07/20/2000CA2360588A1 Human homologues of proteins regulated by circadian rhythms
07/20/2000CA2360386A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
07/20/2000CA2359952A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000CA2359942A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
07/20/2000CA2349180A1 Anthranilic acid derivatives
07/20/2000CA2296224A1 Use of imidazo(1,5-a)pyrido(3,2-e)pyrazinones
07/19/2000EP1019412A1 Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht 1d? receptor antagonists
07/19/2000EP1019409A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
07/19/2000EP1019408A1 1,2,3,4-TETRAHYDRO-BENZOFURO 3,2-c]PYRIDINE DERIVATIVES--
07/19/2000EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
07/19/2000EP1019053A1 Amorphous paroxetine composition
07/19/2000EP1018879A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
07/19/2000EP0679091B1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization
07/19/2000EP0389570B2 High integrity liposomes and method of preration and use
07/19/2000CN1260802A 20-aralkyl-5 'alpha'-pregnane derivatives
07/19/2000CN1260789A Heterocyclic compounds, method for preparing and medicine compositions containing same
07/19/2000CN1260778A Prostaglandin pharmaceutical compositions
07/19/2000CN1260203A Natural product capable of stimulating lactation of domestic animal
07/19/2000CN1054507C Preparation method for medicinal composition for treatment of vaginal infections
07/18/2000US6090945 Tetrahydro-beta-carbolines
07/18/2000US6090848 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
07/18/2000US6090826 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
07/18/2000US6090612 Polynucleotide sequence coding a phosphatase enzymes; a diagnostic tool for monitoring enzyme activity in sample; for treatment of nervous system disorders, cardiovascular disorders and tumors; antitumor agents
07/18/2000CA2117610C Indole derivatives as steroid 5 alpha-reductase inhibitors
07/18/2000CA2093927C Ligand-mediated immunofunctional hormone binding protein assay method
07/13/2000WO2000040725A1 Screening method
07/13/2000WO2000040612A1 Insulin-like growth factor (igf) i mutant variants
07/13/2000WO2000040259A1 Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same
07/13/2000WO2000040248A1 Method and composition for treatment of female sexual dysfunction
07/13/2000WO2000040228A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions
07/13/2000WO2000040226A2 Method of treating sexual disturbances
07/13/2000WO2000040172A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
07/13/2000WO2000024741A3 Dihydropyridine compounds and their use as potassium channel openers
07/13/2000WO2000018801A3 Ncam binding compounds
07/13/2000CA2358495A1 Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same
07/13/2000CA2356412A1 Screening method
07/13/2000CA2356368A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
07/13/2000CA2353592A1 Method and composition for treatment of female sexual dysfunction
07/13/2000CA2350946A1 Method of treating sexual disturbances
07/12/2000EP1018557A2 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
07/12/2000EP1018517A2 Binding agents to CD23 for treatment of inflammatory, autoimmune or allergic diseases
07/12/2000EP1017815A1 Murine model for human carcinoma
07/12/2000EP1017707A1 29 human secreted proteins
07/12/2000EP1017380A1 Topical non-steroidal anti-inflammatory drug composition
07/12/2000EP1017371A4 Controlled release of drugs delivered by sublingual or buccal administration
07/12/2000EP1017371A1 Controlled release of drugs delivered by sublingual or buccal administration
07/12/2000EP1017279A1 Methods for regulating trka expression
07/12/2000EP0877734B1 Quinoline and quinazoline compounds useful in therapy
07/12/2000EP0680336B1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants
07/12/2000CN1259959A GnRh antagonists being modified in positions 5 and 6
07/12/2000CN1259874A Vaginal lactobacillus medicant
07/12/2000CN1259872A NKT cell activators contg. alpha-glycosylceramides
07/12/2000CN1259871A Method of treating chronic progressive vascular scarring diseases
07/12/2000CN1259379A Plaster for treating breast tumour proliferation
07/12/2000CN1259374A Plaster for promoting blood circulation,dispelling wind-evil and transforming calculus
07/12/2000CN1259373A Medicinal pill for protecting safety of fetation
07/12/2000CN1259352A Whole deer prepn.
07/12/2000CN1054377C New bicyclic derivatives of imidazole and their prepn. process, their use as medicaments and the pharmaceutical compositions containing them
07/12/2000CN1054374C New (thia) cycloalkyl [b] indole compounds process for the prepn. thereof and pharmaceutical compositions containing them
07/12/2000CN1054373C Full fluoralkyl-substituted bezoylguanidine prepn. pharmaceutical use of same and pharmaceutical containing same